Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Protein intake deserves special attention on GLP-1 therapy
Sugary Treats: High sugar intake can cause dumping sensations or rapid shifts in insulin that contribute to queasiness
Wegovy is approved for use in adults and children who meet the following body mass index (BMI) and health criteria: adults ages 18 years and older with obesity (BMI of 30 or more) adults ages 18 years and older with overweight (BMI of 27 or more) and at least one weight-related condition, like high blood pressure children ages 12 years and older with obesity (BMI in the 95th percentile or more for their age and sex) The Wegovy product label informs that there have been cases where users without type 2 diabetes experienced low blood sugar (hypoglycemia) when taking other GLP-1 receptor agonist medications
Potential weight loss benefits Both semaglutide and tirzepatide promote weight loss , but the latter has demonstrated superior results in clinical trials
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
